Cornercap Investment Counsel’s AngioDynamics ANGO Stock Holding History

Cornercap Investment Counsel’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-61,390	Closed	-$983K	–	528
2020 Q4	$983K	Buy	+61,390	New	+$779K	0.14%	240
2020 Q1	–	Sell	-69,705	Closed	-$1.12M	–	393
2019 Q4	$1.12M	Buy	69,705 +21,310	+44%	+$325K	0.15%	230
2019 Q3	$891K	Buy	+48,395	New	+$946K	0.13%	329
2019 Q2	–	Sell	-48,395	Closed	-$1.11M	–	414
2019 Q1	$1.11M	Sell	48,395 -690	-1%	-$15K	0.15%	196
2018 Q4	$988K	Buy	49,085 +117	+0.2%	+$2.42K	0.15%	183
2018 Q3	$1.06M	Buy	48,968 +4,073	+9%	+$90.5K	0.14%	243
2018 Q2	$998K	Sell	44,895 -2,230	-5%	-$45.6K	0.14%	168
2018 Q1	$813K	Buy	+47,125	New	+$786K	0.12%	208
2017 Q4	–	Sell	-42,625	Closed	-$728K	–	396
2017 Q3	$728K	Buy	42,625 +6,915	+19%	+$116K	0.1%	296
2017 Q2	$579K	Hold	35,710	–	–	0.1%	257
2017 Q1	$620K	Buy	+35,710	New	+$597K	0.11%	206

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Cornercap Investment Counsel's ANGO Position: Q1 2021 in Review

Cornercap Investment Counsel sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 61,390 shares — an estimated $983K sold.

Cornercap Investment Counsel first reported a position in ANGO in Q1 2017 and held it in 11 quarters. The position peaked at $1.12M in Q4 2019. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

Cornercap Investment Counsel reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
Cornercap Investment Counsel sold 61,390 AngioDynamics shares in Q1 2021, an estimated $983K.
Cornercap Investment Counsel first reported a position in AngioDynamics in Q1 2017 and held it in 11 quarters.
Cornercap Investment Counsel's AngioDynamics position peaked at $1.12M in Q4 2019.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on Cornercap Investment Counsel's 13F filing for Q1 2021, filed 13 May 2021.